发明名称 SUSTAINED RELEASE DELIVERY FORMULATION OF RISPERIDONE COMPOUND
摘要 PROBLEM TO BE SOLVED: To provide a sustained release delivery formulation of a risperidone compound.SOLUTION: There is provided a risperidone sustained release delivery system for treatment of medical conditions related to delusional insanity, schizophrenia, bipolar disorder, psychotic depression, obsessive-compulsive disorder, Tourette's syndrome, and autistic spectrum disorder. This sustained release delivery system includes a flowable composition that contains risperidone and its metabolite or prodrug, and an implant that contains risperidone and its metabolite or prodrug. The flowable composition can be injected into the tissues to clump together into a solid or gelled monolithic implant. The flowable composition includes a biodegradable thermoplastic polymer, an organic liquid, risperidone and its metabolite or prodrug.
申请公布号 JP2013139479(A) 申请公布日期 2013.07.18
申请号 JP20130087247 申请日期 2013.04.18
申请人 TOLMAR THERAPEUTICS INC 发明人 DADEY ERIC
分类号 A61K31/519;A61K9/06;A61K9/08;A61K47/14;A61K47/16;A61K47/20;A61K47/22;A61K47/34;A61P25/18;A61P25/22;A61P25/24 主分类号 A61K31/519
代理机构 代理人
主权项
地址